RHOC and breast cancer: Application of the MitoTracker strategy downstream of the metabolic flux assay revealed that RhoC deletion increases the number of fragmented mitochondria in inflammatory breast cancer cells, which we hypothesize contributes to the depleted OCR levels (Fig. 3g, h).